Skip to main content
OpenTrials
Completed

NCT Number: NCT04346992

Prevalence Of Keratoconus Among Patients With Thyroid Gland Dysfunction

Hormonal imbalances are likely to affect the corneal metabolism and may be also associated with Keratoconus. Among the various endocrinologic dysfunctions assumed so far, thyroid gland dysfunction (TGD) (hypo- or hyperthyroidism; comprised as TGD) is frequently associated with eye diseases such as Graves disease

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Keratoconus in Thyroid Gland Dysfunction

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Fayoum University

Al Fayyum, 63514, Egypt

About this study

Aim of the work

We aim to examine the prevalence of KC among patients already diagnosed by endocrinologist with TGD.

Materials and methods

Our Screening for KC will include evaluation of the demographic data and complete ophthalmological examination of the patients using:

VA Refraction K reading Slit lamp examination Pentacam Study design Epidemiological study

Inclusion citeria All patients diagnosed as thyroid gland dysfunction Control group

Exclusion criteria

Uncooperative patients

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All patients diagnosed as thyroid gland dysfunction

Exclusion criteria

  • Uncooperative patients

Treatment and study plan

No intervention

Other

no intervention

Primary outcomes

  1. prevalence of keratoconus in thyroid gland dysfunction

    Time frame: we will recruit patients who meer the inclusion criteria during the study period April-August 2020

    Our Screening for KC will include evaluation of the demographic data and complete ophthalmological examination of the patients using:

    VA Refraction K reading Slit lamp examination Pentacam

Sponsors and collaborators

Lead sponsor

Fayoum University

Other

Registry information

Important dates

Study start
2020
Primary completion
2022
Study completion
2022
First posted
Apr 15, 2020
Registry last updated
Sep 8, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.